LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹47 Cr | ₹38 Cr | ₹33 Cr | ₹99 Cr | ₹50 Cr |
What is the latest Total Current Liabilities ratio of LYKA LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹38 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹99 Cr |
| Mar2021 | ₹50 Cr |
How is Total Current Liabilities of LYKA LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | 23.45 | |
| Mar2024 | ₹38 Cr | 15.87 | |
| Mar2023 | ₹33 Cr | -67.19 | |
| Mar2022 | ₹99 Cr | 99.18 | |
| Mar2021 | ₹50 Cr | - | |
Compare Total Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹210.6 Cr | 31.8% | -4% | -46.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 31.8% |
-4% |
-46.4% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses